85%Confidence
0Views
FDASource
2026-04-07Date
Summary
Strides Pharma's Class II recall for Children's Ibuprofen due to foreign particles indicates contamination risks that could trigger consumer alarm and brand damage for Taro Pharmaceuticals. This underscores quality challenges in Indian manufacturing and may impact future contract partnerships.
Actionable: Evaluate Taro's supplier oversight and consider diversifying manufacturing sources to mitigate contamination risks.
AI Confidence: 85%
Data Points
firmSTRIDES PHARMA INC
classificationClass II
statusOngoing
distributionU.S.A. Nationwide
productChildren's Ibuprofen Oral Suspension, USP, 100 mg per 5mL, 4 FL OZ (120 mL) bottle, Manufactured for: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now